How do we measure the impact of health interventions and how does the measurement of health or of health’s absence impact global health discourse and funding? How is the measuring of health co-constructive of ideas about what health is and what kinds of negotiations are underway in health development in Senegal as the country works towards universal health coverage?
Health policy-related decisions are often made based on global burden of disease estimates, as well as economic framings of disease control and prevention. But how do other social sciences fit into this agenda – and how do they challenge it?
Between September 25-27, IHME hosted a celebration of the 20th anniversary of the four-part publication of the global burden of disease study in The Lancet by drawing together policy makers from various global health organizations and GBD collaborators from around the world.
In this blog post, I briefly introduce the rise of health economics in the 20th century and a few methods for economically measuring health investment as a means to provide some context to current health care financing debates.